Building a tuberculosis-free world: The Lancet Commission on tuberculosis
MJA Reid, N Arinaminpathy, A Bloom, BR Bloom… - The Lancet, 2019 - thelancet.com
Executive summary Tuberculosis can be treated, prevented, and cured. Rapid, sustained
declines in tuberculosis deaths in many countries during the past 50 years provide …
declines in tuberculosis deaths in many countries during the past 50 years provide …
A trial of early antiretrovirals and isoniazid preventive therapy in Africa
Temprano ANRS 12136 Study … - New England Journal of …, 2015 - Mass Medical Soc
Background In sub-Saharan Africa, the burden of human immunodeficiency virus (HIV)–
associated tuberculosis is high. We conducted a trial with a 2-by-2 factorial design to assess …
associated tuberculosis is high. We conducted a trial with a 2-by-2 factorial design to assess …
Prevalence of tuberculosis in post-mortem studies of HIV-infected adults and children in resource-limited settings: a systematic review and meta-analysis
RK Gupta, SB Lucas, KL Fielding, SD Lawn - Aids, 2015 - journals.lww.com
Objectives: Tuberculosis (TB) is estimated to be the leading cause of HIV-related deaths
globally. However, since HIV-associated TB frequently remains unascertained, we …
globally. However, since HIV-associated TB frequently remains unascertained, we …
Effects of early versus delayed initiation of antiretroviral treatment on clinical outcomes of HIV-1 infection: results from the phase 3 HPTN 052 randomised controlled …
B Grinsztejn, MC Hosseinipour, HJ Ribaudo… - The Lancet infectious …, 2014 - thelancet.com
Background Use of antiretroviral treatment for HIV-1 infection has decreased AIDS-related
morbidity and mortality and prevents sexual transmission of HIV-1. However, the best time to …
morbidity and mortality and prevents sexual transmission of HIV-1. However, the best time to …
[引用][C] Global tuberculosis report 2013
World Health Organization - 2013 - books.google.com
This is the eighteenth global report on tuberculosis (TB) published by WHO in a series that
started in 1997. It provides a comprehensive and up-to-date assessment of the TB epidemic …
started in 1997. It provides a comprehensive and up-to-date assessment of the TB epidemic …
HIV-Associated Tuberculosis
G Meintjes, G Maartens - New England Journal of Medicine, 2024 - Mass Medical Soc
Key Points HIV-Associated Tuberculosis Almost half of inpatients with human
immunodeficiency virus (HIV)–associated tuberculosis in countries with a high disease …
immunodeficiency virus (HIV)–associated tuberculosis in countries with a high disease …
Tuberculosis comorbidity with communicable and non-communicable diseases: integrating health services and control efforts
Recent data for the global burden of disease reflect major demographic and lifestyle
changes, leading to a rise in non-communicable diseases. Most countries with high levels of …
changes, leading to a rise in non-communicable diseases. Most countries with high levels of …
Isoniazid plus antiretroviral therapy to prevent tuberculosis: a randomised double-blind, placebo-controlled trial
Background Antiretroviral therapy reduces the risk of tuberculosis, but tuberculosis is more
common in people with HIV than in people without HIV. We aimed to assess the effect of …
common in people with HIV than in people without HIV. We aimed to assess the effect of …
The transmission of Mycobacterium tuberculosis in high burden settings
Unacceptable levels of Mycobacterium tuberculosis transmission are noted in high burden
settings and a renewed focus on reducing person-to-person transmission in these …
settings and a renewed focus on reducing person-to-person transmission in these …
Trends in AIDS deaths, new infections and ART coverage in the top 30 countries with the highest AIDS mortality burden; 1990–2013
R Granich, S Gupta, B Hersh, B Williams, J Montaner… - PloS one, 2015 - journals.plos.org
Background Antiretroviral therapy (ART) prevents human immunodeficiency virus (HIV)
disease progression, mortality and transmission. We assess the impact of expanded HIV …
disease progression, mortality and transmission. We assess the impact of expanded HIV …